Abstract | AIM: MATERIALS & METHODS: Caspase-2L and -2S transcript levels were determined in paired tumor and non-malignant control tissues from 64 patients after neoadjuvant chemotherapy and 100 pretreatment patients (general set) by real-time PCR with absolute quantification. RESULTS: Low but statistically significant upregulation of caspase-2L in tumor versus control tissues was observed in both sets. Significant associations of the levels of caspase-2L, -2S or S/L ratio with clinical prognostic factors were observed. However, none of these associations were confirmed in both sets. Levels of caspase-2 isoforms or the S/L ratio did not significantly associate with progression-free survival in the general set or with chemotherapy response in the neoadjuvant set. CONCLUSION:
|
Authors | Veronika Brynychová, Viktor Hlaváč, Marie Ehrlichová, Radka Václavíková, Václav Pecha, Markéta Trnková, Martin Wald, Marcela Mrhalová, Kateřina Kubáčková, Tomáš Pikus, Roman Kodet, Jan Kovář, Pavel Souček |
Journal | Future oncology (London, England)
(Future Oncol)
Vol. 9
Issue 3
Pg. 427-38
(Mar 2013)
ISSN: 1744-8301 [Electronic] England |
PMID | 23469978
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Isoenzymes
- RNA, Messenger
- CASP2 protein, human
- Caspase 2
- Cysteine Endopeptidases
|
Topics |
- Adult
- Aged
- Breast Neoplasms
(enzymology, mortality)
- Carcinoma, Ductal, Breast
(enzymology, mortality)
- Caspase 2
(genetics, metabolism)
- Chemotherapy, Adjuvant
- Cysteine Endopeptidases
(genetics, metabolism)
- Female
- Gene Frequency
- Humans
- Isoenzymes
(genetics, metabolism)
- Kaplan-Meier Estimate
- Middle Aged
- Neoadjuvant Therapy
- RNA, Messenger
(genetics, metabolism)
- Sequence Analysis, DNA
- Up-Regulation
|